Kairos Pharma, Ltd. (KAPA) short interest & options flow
AMEXKairos Pharma heads into its May 13 earnings print with short sellers beating a notable retreat — and the lending market loosening to match. Short interest has fallen nearly half over the past month. It dropped 27% in a single week to roughly 0.66% of the free float, extending a sharper monthly unwind of 45%. The absolute level is small — around 138,000 shares short — but the speed…
KAPA short interest drops 27% in one week to 0.66% of float, driven by covering activity as stock declines.
- Market cap
- $2M
- Next earnings
- 13 Nov 2026
Key data as of 12 Nov 2026
Latest signals on KAPA
- Short Interest
KAPA short interest drops 27% in one week to 0.66% of float, driven by covering activity as stock declines.
KAPA news and analysis
RSSNo long-form analysis yet for KAPA. Pulse alerts and the live data picture are available on ORTEX.
Open KAPA on ORTEX →Want the live picture for KAPA?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for KAPA — free to start on ORTEX.
Sign up for free →Open KAPA on ORTEX